TY - JOUR
T1 - Idiopathic pulmonary arterial hypertension
T2 - Current state of play and new treatment modalities
AU - Gibbs, J. Simon R.
AU - Broberg, Craig S.
AU - Gatzoulis, Michael A.
PY - 2004/12
Y1 - 2004/12
N2 - Research in pulmonary hypertension has led to exciting advances over the last decade, both in terms of understanding aetiology and expanding treatment options. This review highlights the current approach to classification and disease management. In particular, we review the significant data and recommendations on the use of prostacyclin analogues, endothelin receptor antagonists, phosphodiesterase inhibitors and drug combinations.
AB - Research in pulmonary hypertension has led to exciting advances over the last decade, both in terms of understanding aetiology and expanding treatment options. This review highlights the current approach to classification and disease management. In particular, we review the significant data and recommendations on the use of prostacyclin analogues, endothelin receptor antagonists, phosphodiesterase inhibitors and drug combinations.
KW - Phosphodiesterase
KW - Prostacyclin
KW - Pulmonary hypertension
UR - http://www.scopus.com/inward/record.url?scp=10044223335&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=10044223335&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2004.08.003
DO - 10.1016/j.ijcard.2004.08.003
M3 - Article
C2 - 15590073
AN - SCOPUS:10044223335
SN - 0167-5273
VL - 97
SP - 7
EP - 10
JO - International Journal of Cardiology
JF - International Journal of Cardiology
IS - SUPPL. 1
ER -